β-thalassemia patient sera. In conclusion, hepcidin suppression in β-thalassemia is associated with the down-regulation of ATOH8 in response to anemia. We, therefore, suggest that ATOH8 is an important transcriptional regulator of hepcidin in β-thalassemia.
Introduction
Hepcidin is a 25-amino acid peptide hormone produced by hepatocytes in the liver [1] [2] [3] [4] [5] . It plays a critical role in balancing the systemic iron homeostasis, by inducing the internalization and degradation of the iron-exporter ferroportin on enterocytes, and hepatocytes and macrophages in the spleen [6] [7] [8] [9] [10] . Increased hepcidin production inhibits absorption of dietary iron and release of iron from hepatocytes and macrophages in the spleen, resulting in limitation of iron overload. Hepatic hepcidin transcription can be regulated by changes in iron levels via the bone morphogenic protein (BMP) signaling pathway, inflammation via signal transducer and activation of transcription 3 (STAT-3) signaling pathway, and erythropoietic stimuli. Hepcidin expression is induced by iron overload and inflammation, whereas it is suppressed by iron deficiency and increased erythropoietic activity [11] [12] [13] [14] . β-Thalassemia is a hereditary blood disorder with ineffective erythropoiesis; β-thalassemia patients suffer from anemia and secondary iron overload, occurring from increased duodenal absorption and regular blood transfusions [15] . Interestingly, it has been reported that hepcidin suppression in β-thalassemia might result from the dominant influence of anemia through erythropoietic stimuli [e.g., growth differentiation factor 15 (GDF15), twisted gastrulation protein homolog 1 (TWSG1), or erythroferrone (ERFE)], which overrides the hepcidin activation induced by iron overload [16] [17] [18] . Reduced urinary and serum hepcidin levels seen in β-thalassemia patients can lead to increased duodenal iron absorption which can exacerbate the iron overload condition [19] [20] [21] [22] [23] .
Recently, atonal homolog 8 (ATOH8) has been identified as a novel positive regulator of hepcidin transcription via two independent mechanisms: E-box-dependent transcriptional activation and an increase of cellular phosphorylated sons of mothers against decapentaplegic 1, 5, 8 (pSMAD1, 5, 8) levels in the BMP signaling pathway. The down-regulation of ATOH8 was observed in hypotransferrinemic mice with anemia, which appears to override the activation of ATOH8 as a result of the increased iron levels [24] . This explains how hepcidin suppression was caused by anemia in the conditions of liver iron loading and increased BMP6 levels without any changes in pSMAD1,5,8 levels [25] . Therefore, ATOH8 links between erythropoietic activity and iron-sensing molecules to hepcidin transcription. Given that anemia dominantly suppressed ATOH8 expression as well as hepcidin expression, we hypothesize that ATOH8 is involved in hepcidin expression in β-thalassemia. [26, 27] . The study protocol was approved by the Animal Ethical Committee of Faculty of Medicine, Chiang Mai University, Thailand (Reference Number 42/2556). The mice were sacrificed and their plasma, liver, and spleen were collected. Hematological and iron metabolism-related parameters, including red blood cell (RBC) morphology, plasma non-transferrin bound iron (NTBI), hepatic and splenic iron, hepatic pSMAD1,5,8, and hepatic mRNA of Hamp1, Atoh8, and Bmp6, in mice were investigated. RBC morphology was detected from peripheral blood smear using Wright-Giemsa stain according to the manufacturer's protocol. Plasma NTBI levels were estimated by chelatable fluorescent beads based on flow cytometry [28] . Hepatic and splenic irons were analyzed by Perl's Prussian blue stain and ferrozine colorimetric method [29] . pSMAD1,5,8 levels were detected by western blot analysis. Hamp1, Atoh8, and Bmp6 mRNA expressions were determined using qPCR method.
Materials and methods

Chemicals and reagents
1X
β-Thalassemia serum
Blood samples were collected from 10-to 18-yearold HbE/β-thalassemia patients (HbE/T) (11 males, 12 females) and β-thalassemia major patients (TM) (9 males, 6 females) who regularly visit the Thalassemia Clinic at Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. All patients displayed anemia with average hemoglobin (Hb) levels of 6-7 g/dL. They are transfusion-dependent thalassemia and are regularly treated with iron chelator(s), including: deferoxamine, deferiprone, or deferasirox. The study protocol was approved by the Research Ethics Committee, Faculty of Medicine, Chiang Mai University, Thailand (Research ID: 2151/Study Code: BIO-2556-02151). Their venous blood was collected and all obtained serum samples were pooled in the same patient group for further analysis and study. Normal human serum (Invitrogen, UK) was used as the control. Blood hematological and iron metabolism-related parameter levels, including serum iron (SI), total iron binding capacity (TIBC), transferrin saturation (TS), NTBI, ferritin, hepcidin, and erythropoietin (EPO), in all the pooled serum groups were determined. SI and TIBC were measured colorimetrically at the Clinical Chemistry Laboratory, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand with an automated analyzer according to the manufacturer's instructions. Serum NTBI was quantified using nitrilotriacetic acid chelation/HPLC method [29] . Serum ferritin concentrations were analyzed using a latex-enhanced immunoturbidimetric assay on the Roche/Hitachi 917 automated machine (Hamiya Biomedical Company, USA). Serum hepcidin concentrations were measured using hepcidin ELISA Kit according to the manufacturer's protocol. Serum EPO concentrations were estimated using EPO ELISA Kit on IMMULITE ® 1000 automated machine (Siemens Healthcare Diagnostics Products, UK).
Cell culture
Human hepatoma (Huh7) cell line was routinely cultured in DMEM supplemented with 10% (v/v) FBS, 2 mM l-glutamine, and 1% (v/v) penicillin-streptomycin at 37 °C under humidified 5% CO 2 atmospheric conditions. To imitate β-thalassemia patients, grown cells (60% confluent) were initially cultured in serum-free DMEM containing 1% (v/v) penicillin-streptomycin for 24 h (starvation step) and subsequently grown in DMEM supplemented with 20% (v/v) human sera (normal, HbE/T and TM), 2 mM l-glutamine and 1% (v/v), penicillin-streptomycin (DMEM + ) for another 24 h [30] .
ATOH8 transfection
To study the effect of ATOH8 on hepcidin expression, over-expression of ATOH8 was induced in the cells by transfection. Before culturing in DMEM + , the Huh7 cells were transfected with ATOH8-FLAG expression plasmid in DMEM for 24 h in the starvation step of cell culture. The transfection was performed using Fugene ® HD transfection reagent according to the manufacturer's instructions. The ATOH8-FLAG expression plasmid, a plasmid expressing Myc-DDK-tagged ORF clones of Atonal homolog 8 (Drosophila), is transfection-ready DNA.
Quantitative real-time polymerase chain reaction (qPCR) method
RNA was extracted from mouse livers (100 mg wet weight each) and cultured cells using TRIzol reagent. The genomic DNA was removed using an Illustra RNAspin Mini RNA Isolation Kit according to the manufacturer's protocol. RNA (1 µg) was reverse transcribed to cDNA using a High Capacity cDNA Reverse Transcription Kit. The qPCR reactions of the cDNA samples were performed using an EXPRESS SYBR ® GreenER™ qPCR Supermix Universal Kit on the ABI 7500 fast real-time PCR machine (Applied Biosystems, UK) according to the manufacturer's protocol.
The primers used in qPCR for mouse samples were: Hamp1 forward: CCTGAGCAGCACCACCTATC, Hamp1 reverse: TGCAACAGATACCACACTGGG [29] , Atoh8 forward: TCAGCTTCTCCGAGTGTGTG, Atoh8 reverse: TAGCCTGTGGCAGGTCACT [24] , Bmp6 forward: AACAGCTTGCAAGAAGCATGAG, Bmp6 reverse: TGGACCAAGGTCTGTACAATGG [25] , Actb forward: GGTCCACACCCGCCAC, Actb reverse: GTCCTTCT-GACCCATTCCCA [29] . The expression of Hamp1, Atoh8, or Bmp6 mRNA was normalized to housekeeping β-actin (Actb) mRNA and is expressed as fold changes using the ΔΔCT method [31] .
The primers used in qPCR for cultured cell samples were: HAMP forward: CAGTGGCTCTGTTTTCCCAC, HAMP reverse: GTCTTGCAGCACATCCCACA, ATOH8 forward:
GCCTCCTCCGAGATCAAAGC, ATOH8 reverse: TGCCCATATGAGTAGCACGG, RPL19 forward: GCTCTTTCCTTTCGCTGCT, RPL19 reverse: CATTG-GTCTCATTGGGGTCT [24] . The expression of HAMP or ATOH8 mRNA was normalized to housekeeping ribosomal protein L19 (RPL19) mRNA and is expressed as fold changes using the ΔΔCT method.
Western blot analysis
Whole cell lysates from mouse livers or cultured cells were prepared by homogenizing in radioimmunoprecipitation assay (RIPA) buffer [10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, and 0.1% sodium dodecyl sulphate (SDS)] containing protease and phosphatase inhibitor cocktails. The homogenates were centrifuged at 1000×g at 4 °C for 5 min. The protein supernatant was collected to estimate protein concentrations using BioRad Protein Assay (Lowry). 9 μg of cell proteins and 50 µg of liver proteins were subjected to 15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad, USA). Proteins were then transferred to a nitrocellulose membrane using Trans-Blot ® SD Cell (Bio-Rad, USA). The membrane was blocked with 5% skim milk in PBST (0.05% Tween-20 in phosphate buffer saline (PBS)). pSMAD1,5,8, ATOH8-FLAG, total SMAD1,5,8, and β-actin proteins were detected using monoclonal rabbit anti-phospho-Smad1/Smad5/Smad8 antibody (1:1000), polyclonal rabbit anti-DYKDDDDK Tag antibody (Anti-FLAG antibody) (1:1000), polyclonal rabbit antiSmad1/5/8 antibody (1:200), and monoclonal rabbit anti-β-actin (1:1000) in 1% skim milk in PBST, respectively.
Goat anti-rabbit IgG/HRP antibody (1:1000) in 1% skim milk in PBST was used as a second antibody. The western blot signals were visualized by chemiluminescense using SuperSignal ® West Femto Maximum Sensitivity Substrate (for pSMAD1,5,8 and total SMAD1,5,8 proteins) and ECL™ Prime Western Blotting Detection Reagent (for ATOH8-FLAG and β-actin proteins). The signal bands were photographed by Universal Hood II (Bio-Rad, USA). The densitometry of protein bands was estimated by the Phoretix TotalLab TL120 software. pSMAD1,5,8 and ATOH8-FLAG protein levels were normalized to total SMAD1,5,8 or β-actin and are expressed as fold changes in comparison with the control group.
Statistical analysis
The data were analyzed using the IBM SPSS Statistics 20 program and are expressed as mean ± SD. Statistical significance was determined using Student's unpaired t test or one-way analysis of variance (1-way ANOVA) with Tukey's post hoc test. The linear correlation between continuous variables was analyzed by Pearson correlation coefficients. The p value <0.05 was considered significant.
Results
Hepcidin suppression in β-thalassemia mice correlated with a reduction of ATOH8 levels
With the hypothesis that ATOH8 is involved in hepcidin expression in β-thalassemia, the levels of hepatic Hamp1 mRNA, Atoh8 mRNA, and pSMAD1,5,8 protein in β-thalassemic (BKO) mice were investigated. BKO mice exhibited anemia and iron loading symptoms. The peripheral blood smear showed hypochromic microcytic red blood cells (Fig. 1a) . The levels of iron loading parameters, including hepatic Bmp6 mRNA, plasma NTBI, and hepatic and splenic iron content in BKO mice, were significantly higher than in wild-type (WT) mice (Fig. 1b-e) . Perl's Prussian blue staining result also supported more iron accumulation in BKO mice (Table 1) . Expectedly, Bmp6 mRNA levels have the correlation with only hepatic iron content (R = 0.665; p = 0.001; n = 20) (Fig. 1f) . We demonstrated that hepatic Hamp1 and Atoh8 mRNA levels in BKO mice were significantly lower than in WT mice (Fig. 2a, b) . Interestingly, Hamp1 mRNA levels correlated with Atoh8 mRNA levels (R = 0.471; p = 0.036; n = 20) (Fig. 2c) . However, there were no significant differences in pSMAD1,5,8 levels between both mice (data not shown), Fig. 1 Hematological and iron metabolism-related parameters in wild-type (WT) and β-thalassemic (BKO) mice: Wright-Giemsa staining result in the peripheral blood smear (a), hepatic Bmp6 mRNA levels (b), plasma NTBI concentrations (c), hepatic iron content (d), and splenic iron content (e) were determined. The data (mean ± SD) were obtained from WT mice (5 males, 5 females) and BKO mice (5 males, 5 females) to compare with WT mice. Statistical analysis was performed using Student's unpaired t test. The correlation curve between hepatic Bmp6 mRNA levels and hepatic iron content (f) was analyzed by Pearson correlation coefficients. *p < 0.05 although the BKO mice displayed hepatic iron loading and an increase of BMP6 (Fig. 1b, d ).
Hepcidin inhibition induced by β-thalassemia patient sera correlated with a decrease of ATOH8 levels
To imitate β-thalassemia patients, we cultured Huh7 cells in DMEM medium supplemented with HbE/T male, HbE/T female, TM male, and TM female sera in comparison with FBS and normal serum. Blood hematological and iron metabolism-related parameters in the pooled serum groups were analyzed and shown in Table 2 . Levels of serum iron, transferrin saturation, NTBI, ferritin, and EPO were much higher in all β-thalassemia patient sera than in normal serum. Hepcidin concentrations in the β-thalassemia sera (except TM male) were slightly higher than in the normal serum. The data confirmed iron overload and increased erythropoiesis with anemia in the β-thalassemia patient serum samples when compared to the normal serum and a reference range. Compared among the patient serum groups, TM male serum showed more iron overload with the highest values of serum iron and ferritin and also exhibited more increased erythropoiesis with the highest EPO levels. HAMP and ATOH8 mRNA levels in Huh7 cells were much lower in all β-thalassemia patient serum-supplemented medium than in FBS culture medium as well as in normal serum-supplemented medium (p < 0.05) (Fig. 3a,  b ). Yet, the differences were not found between different types and genders. Significant correlation was detected in HAMP and ATOH8 mRNA levels (R = 0.971; p < 0.001; n = 18) (Fig. 3c) . Moreover, pSMAD1,5,8 levels in all patient groups were not different from the normal group, although the incubation time was varied (3, 6, 12, and 24 h) (data not shown).
Over-expression of ATOH8 overcame hepcidin suppression, induced by β-thalassemia patient sera
To determine whether ATOH8 regulates hepcidin expression in β-thalassemia, Huh7 cells were transfected with 0, 0.5, 1, and 2 µg of ATOH8-FLAG expression plasmid and subsequently grown in DMEM medium supplemented with HbE/T female serum. The ATOH8 transfection could dramatically increase both ATOH8 mRNA and ATOH8-FLAG protein levels at 0.5 and 1 µg, then declining at 2 µg of ATOH8-FLAG expression plasmid (Fig. S1a, c) . Consistently, the ATOH8 transfection could up-regulate HAMP mRNA expression in a dose-dependent manner at 0.5 and 1 µg of ATOH8-FLAG expression plasmid, decreasing at 2 µg of the plasmid (p < 0.05) (Fig. S1b) . Expectedly, the ATOH8 transfection elevated pSMAD1,5,8 levels in the same pattern in both total SMAD1,5,8 and β-actin normalization (Fig. S2) . It was clear that the transfection with 1 µg of ATOH8-FLAG expression plasmid could raise ATOH8 levels in both mRNA and protein levels (Fig. 4a, d ) and enhance HAMP mRNA expression (Fig. 4b ) in all sera. Interestingly, over-expression of ATOH8 could overcome the inhibition of hepcidin expression in β-thalassemia patient serum culture in comparison with FBS and normal serum culture (Fig. 4c) .
Discussion
Identification and understanding of the roles of hepcidin regulators in β-thalassemia might lead to the development of new therapies and management strategies for β-thalassemia patients. In β-thalassemia, it has been hypothesized so far that hepcidin suppression resulting from anemia through erythropoietic stimuli (e.g., GDF15, TWSG1, or ERFE) overrides hepcidin activation induced by iron overload [16] [17] [18] 32] . GDF15, TWSG1, and ERFE produced by erythroid precursors have been reported as negative regulators of hepcidin transcription [16] [17] [18] . GDF15 levels were elevated in β-thalassemia patient serum with low hepcidin levels; it also suppressed HAMP mRNA expression in human hepatocyte cultures [16] . In contrast, hepcidin expression was suppressed in GDF15 knockout mice (Gdf-15 −/− ) subjected to phlebotomy, and bone-marrow GDF15 levels were not increased in the β-thalassemic mice [33] . Therefore, the relationship between GDF15 and hepcidin regulation remains controversial. TWSG1 inhibited Fig. 3 Effect of β-thalassemia patient sera on HAMP and ATOH8 mRNA expression in Huh7 cells. Huh7 cells were grown in the DMEM + for 24 h and subjected to qPCR analysis for HAMP (a) and ATOH8 (b) mRNA expression. Relative mRNA expression was acquired by normalizing to RPL19. Values (mean ± SD) obtained from triplicate samples are expressed as fold changes compared with the normal serum group. Statistical analysis was performed using one-way ANOVA with Tukey's post hoc test. # p < 0.05 compared to FBS; *p < 0.05 compared to the normal serum. Their correlation analysis (c) was determined by Pearson correlation coefficients. *p < 0.05. HbE/T: HbE/β-thalassemia; TM: β-thalassemia major Fig. 4 Effect of ATOH8 transfection on ATOH8 and hepcidin expression in Huh7 cells grown in the β-thalassemia patient sera. Huh7 cells were transfected with 1 µg of ATOH8-FLAG expression plasmid and grown in the DMEM + for 24 h. The cells were subjected to qPCR analysis for ATOH8 (a) and HAMP (b, c) mRNA expression. Relative mRNA expression was acquired by normalizing to RPL19. In a and b, values (mean ± SD) obtained from triplicate samples are expressed as fold changes compared with the group without ATOH8-FLAG expression plasmid; statistical analysis was performed using Student's unpaired t test. In c, values (mean ± SD) obtained from triplicate samples are expressed as fold changes compared with the normal serum group; statistical analysis was performed using oneway ANOVA with Tukey's post hoc test.
# p < 0.05 compared to FBS; *p < 0.05 compared to the normal serum. The whole cell lysates of biological triplicate samples were also subjected to western blot analysis to detect ATOH8-FLAG protein levels (d). HbE/T: HbE/β-thalassemia; TM: β-thalassemia major BMP-mediated hepcidin expression in human hepatocyte cultures and was up-regulated in the β-thalassemic mice [17] . While ERFE (Fam132b) mRNA expression was increased in β-thalassemic mice, ERFE-deficient mice failed to exhibit hepcidin suppression after hemorrhage [18] . However, human correlative studies of TWSG1 and ERFE and hepcidin expression are not investigated yet. Altogether, the study of hepcidin regulation by those erythroid cell-derived humoral factors in β-thalassemia is still contradictory. Therefore, hepcidin transcriptional regulation within hepatocytes by physiological transcription factor(s) should be investigated to verify the roles of humoral factors in hepcidin suppression in β-thalassemia. Here, we investigated the influence of ATOH8, a novel transcription factor, on hepcidin expression in β-thalassemic mice and in Huh7 cells cultured in β-thalassemia patient sera.
Previous studies have shown that hepcidin expression is down-regulated in β-thalassemic mice [34] [35] [36] [37] [38] [39] . The β-thalassemic mice used in this study displayed hypochromic microcytic red blood cells. They are heterozygous β-globin knockout ( mu β th−3/+ ) mice, exhibiting ineffective erythropoiesis, mild anemia (approximately 8 g/dL of Hb levels), and splenic enlargement [26] . For the first time, our study has shown the correlation between hepcidin and ATOH8 expression; both hepatic Hamp1 and Atoh8 mRNA expression were down-regulated in β-thalassemic mice in comparison with wild-type mice. This is in accordance with the suppression of hepatic Hamp1 mRNA, Atoh8 mRNA, and ATOH8 protein expression in other mouse models with increased erythropoietic activity (e.g., hemolytic anemia, hypoxia, EPO treatment, and hypotransferrinemia) [24, [40] [41] [42] [43] [44] . To imitate β-thalassemia, the effects of β-thalassemia patient sera on both hepcidin and ATOH8 expression in Huh7 cells were investigated. Interestingly, HepG2 cells grown in the medium containing the thalassemia sera revealed the down-regulation of hepcidin expression [30, 45] . Although most previous studies have reported that hepcidin levels in β-thalassemia patients are low [19] [20] [21] [22] [23] , some publications conversely reported that hepcidin levels were higher in β-thalassemia major (TM) compared to β-thalassemia intermediate (TI) and normal [21, 46] . Kemna and colleagues previously showed the down-regulation of hepcidin expression in HepG2 cells cultured in the medium supplemented with TM serum, where hepcidin concentrations were insignificantly lower than in the normal serum [45] . Similarly, β-thalassemia sera (except TM male serum) used in our study contained slightly higher hepcidin concentrations than in the normal serum. This might result from increased iron loading and the relief of ineffective erythropoiesis due to chronic transfusion [19, 47] . All sera were collected from transfusiondependent thalassemia patients with anemia symptoms (average 6-7 g/dL of Hb levels). The pooled patient sera showed much higher levels of EPO than the normal serum, indicating more increased erythropoiesis. However, EPO levels among patient sera were also different; TM male serum had the highest levels. Clearly, both HAMP and ATOH8 mRNA expression were down-regulated in Huh7 cells grown in culture medium supplemented with the sera of HbE/T or TM patients when compared with FBS and normal serum. There were no differences between patient types and genders. The reduction of HAMP mRNA levels correlated with the decrease of ATOH8 mRNA levels. Altogether, this suggested that the humoral factors, especially erythropoietic stimuli but not EPO, in the patient sera still exert their effects on hepcidin and ATOH8 expression. This also suggests that hepcidin and ATOH8 suppression in β-thalassemia by anemia might not be directly mediated by EPO. It is probably linked by some erythropoietic stimuli (e.g., ERFE) [18, 44] .
In addition to increased erythropoietic activity, ATOH8 expression responds to the change of iron levels. Hepatic Hamp1 and Atoh8 mRNA levels increased in mice fed with an iron supplemented-diet and in mice treated with holotransferrin, but decreased in mice fed with an iron deficientdiet [24, 48] . Conversely, hepatic Hamp1 mRNA, Atoh8 Mrna, and ATOH8 protein expression were down-regulated in hypotransferrinemic mice with a high degree of chronic anemia and liver iron overload [24] . Atoh8 mRNA expression was also inhibited in Hamp1 −/− after phenylhydrazine (PHZ) treatment, although their serum iron levels were still high [24, 42] . Since ATOH8 stimulates hepcidin transcription by two independent mechanisms: binding to E-box transcription factor binding sites and increasing cellular pSMAD1,5,8 levels, the decrease of hepatic ATOH8 may abolish the effect of increased BMP6 levels on pSMAD1,5,8 levels and decrease E-box transcriptional activation [24] . This would also explain how hepcidin suppression occurs by anemia despite hepatic iron loading and BMP6 increasing without any change of pSMAD1,5,8 levels [25] . Therefore, it appears that erythropoietic regulators from anemia override iron store regulators from iron overload in hepcidin expression as in hypotransferrinemia and β-thalassemia [16-18, 23, 24, 32, 49] . Similarly, we found the reduction of Hamp1 and Atoh8 mRNA levels in β-thalassemic mice, although Bmp6 mRNA levels, plasma NTBI concentrations, and hepatic and splenic iron contents were higher than in wild-type mice. In Huh7 cells cultured in β-thalassemia patient sera, HAMP and ATOH8 mRNA expression were also suppressed, even though their serum iron, transferrin saturation, NTBI, and ferritin levels were high. These two β-thalassemia models revealed the correlation of hepcidin and ATOH8 suppression without the alteration of pSMAD1,5,8 levels. These results suggested that the up-regulation of ATOH8 by iron overload was possibly overridden by the down-regulation of ATOH8 by anemia mediated by some erythropoietic stimuli, similar to the regulation of hepcidin. Therefore, ATOH8 expression in β-thalassemia is suppressed by anemia in a similar manner and the same direction as hepcidin expression.
Previously, Patel and colleagues investigated ATOH8 function in hepcidin transcription by transfecting ATOH8-FLAG expression plasmid into HEK293 cells. From this models, they demonstrated that ATOH8 stimulates hepcidin transcription by two mechanisms: directly via E-boxes and indirectly through increased pSMAD1,5,8 levels. In the latter mechanism, ATOH8 transfection could increase pSMAD1,5,8 levels as well as hepcidin expression (mRNA levels and promoter activity) [24] . Thus, to investigate the effect of ATOH8 on hepatic hepcidin expression in β-thalassemia, Huh7 cells were transfected with ATOH8-FLAG expression plasmid and then cultured in β-thalassemia patient sera. Similar to HEK293 cells (Figs. S3, S4 ), the ATOH8 transfection in Huh7 cells could increase the levels of ATOH8 mRNA, ATOH8-FLAG protein, pSMAD1,5,8, and HAMP mRNA (Figs. S1, S2 ). Therefore, in Huh7 cells, ATOH8 also regulates hepcidin expression via BMP signaling pathway by increasing pSMAD1,5,8 levels. Over-expression of ATOH8 from the ATOH8-FLAG expression plasmid transfection could overcome the hepcidin suppression. Indeed, this indicates that the inhibition of hepcidin production in β-thalassemia results from the down-regulation of ATOH8.
In conclusion, hepcidin suppression in β-thalassemia is associated with the down-regulation of ATOH8 in response to anemia. Therefore, ATOH8 is proposed to be a transcriptional regulator of hepcidin in β-thalassemia. These findings open new potential developmental routes for novel hepcidin agonists to stimulate hepcidin production to lower iron overload in β-thalassemia patients.
